Johnson Investment Counsel’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $263K | Sell |
1,216
-30
| -2% | -$5.74K | ﹤0.01% | 765 |
|
|
2026
Q1 | $228K | Sell |
1,246
-23
| -2% | -$4.24K | ﹤0.01% | 769 |
|
|
2025
Q4 | $223K | Sell |
1,269
-160
| -11% | -$26.1K | ﹤0.01% | 748 |
|
|
2025
Q3 | $200K | Buy |
+1,429
| New | +$193K | ﹤0.01% | 805 |
|
|
2025
Q2 | – | Sell |
-1,513
| Closed | -$207K | – | 822 |
|
|
2025
Q1 | $207K | Sell |
1,513
-166
| -10% | -$23.7K | ﹤0.01% | 756 |
|
|
2024
Q4 | $257K | Sell |
1,679
-386
| -19% | -$65.1K | ﹤0.01% | 691 |
|
|
2024
Q3 | $400K | Buy |
2,065
+100
| +5% | +$20.9K | ﹤0.01% | 558 |
|
|
2024
Q2 | $456K | Sell |
1,965
-90
| -4% | -$19.6K | ﹤0.01% | 512 |
|
|
2024
Q1 | $443K | Hold |
2,055
| – | – | ﹤0.01% | 528 |
|
|
2023
Q4 | $532K | Buy |
2,055
+144
| +8% | +$35.4K | 0.01% | 472 |
|
|
2023
Q3 | $491K | Sell |
1,911
-19
| -1% | -$5.08K | 0.01% | 469 |
|
|
2023
Q2 | $550K | Sell |
1,930
-235
| -11% | -$70K | 0.01% | 446 |
|
|
2023
Q1 | $602K | Sell |
2,165
-15
| -0.7% | -$4.15K | 0.01% | 428 |
|
|
2022
Q4 | $604K | Buy |
2,180
+31
| +1% | +$8.76K | 0.01% | 426 |
|
|
2022
Q3 | $574K | Sell |
2,149
-72
| -3% | -$15.3K | 0.01% | 412 |
|
|
2022
Q2 | $453K | Buy |
2,221
+190
| +9% | +$38.8K | 0.01% | 466 |
|
|
2022
Q1 | $428K | Buy |
2,031
+5
| +0.2% | +$1.09K | 0.01% | 504 |
|
|
2021
Q4 | $486K | Sell |
2,026
-7
| -0.3% | -$1.8K | 0.01% | 475 |
|
|
2021
Q3 | $575K | Sell |
2,033
-30
| -1% | -$9.83K | 0.01% | 419 |
|
|
2021
Q2 | $714K | Sell |
2,063
-47
| -2% | -$14.2K | 0.01% | 378 |
|
|
2021
Q1 | $590K | Sell |
2,110
-1,178
| -36% | -$318K | 0.01% | 391 |
|
|
2020
Q4 | $805K | Sell |
3,288
-164
| -5% | -$42.3K | 0.01% | 339 |
|
|
2020
Q3 | $979K | Sell |
3,452
-33
| -0.9% | -$9.2K | 0.02% | 286 |
|
|
2020
Q2 | $932K | Sell |
3,485
-46
| -1% | -$13.8K | 0.02% | 293 |
|
|
2020
Q1 | $1.12M | Sell |
3,531
-588
| -14% | -$178K | 0.02% | 229 |
|
|
2019
Q4 | $1.22M | Sell |
4,119
-191
| -4% | -$53K | 0.02% | 273 |
|
|
2019
Q3 | $1M | Sell |
4,310
-816
| -16% | -$190K | 0.02% | 306 |
|
|
2019
Q2 | $1.2M | Sell |
5,126
-39
| -0.8% | -$9.01K | 0.02% | 271 |
|
|
2019
Q1 | $1.22M | Sell |
5,165
-1,435
| -22% | -$452K | 0.03% | 280 |
|
|
2018
Q4 | $1.99M | Sell |
6,600
-488
| -7% | -$156K | 0.05% | 192 |
|
|
2018
Q3 | $2.5M | Sell |
7,088
-11,013
| -61% | -$3.79M | 0.06% | 183 |
|
|
2018
Q2 | $5.25M | Sell |
18,101
-770
| -4% | -$216K | 0.13% | 114 |
|
|
2018
Q1 | $5.17M | Sell |
18,871
-3,810
| -17% | -$1.18M | 0.13% | 109 |
|
|
2017
Q4 | $7.22M | Sell |
22,681
-2,255
| -9% | -$723K | 0.18% | 96 |
|
|
2017
Q3 | $7.81M | Buy |
24,936
+428
| +2% | +$127K | 0.21% | 86 |
|
|
2017
Q2 | $6.65M | Sell |
24,508
-1,253
| -5% | -$331K | 0.19% | 93 |
|
|
2017
Q1 | $7.04M | Sell |
25,761
-604
| -2% | -$171K | 0.2% | 90 |
|
|
2016
Q4 | $7.48M | Sell |
26,365
-4,076
| -13% | -$1.21M | 0.23% | 84 |
|
|
2016
Q3 | $9.53M | Sell |
30,441
-2,850
| -9% | -$844K | 0.3% | 75 |
|
|
2016
Q2 | $8.05M | Buy |
33,291
+239
| +0.7% | +$63K | 0.27% | 83 |
|
|
2016
Q1 | $8.6M | Buy |
33,052
+697
| +2% | +$184K | 0.3% | 68 |
|
|
2015
Q4 | $9.91M | Sell |
32,355
-4,055
| -11% | -$1.17M | 0.35% | 64 |
|
|
2015
Q3 | $10.6M | Buy |
36,410
+5,048
| +16% | +$1.67M | 0.39% | 61 |
|
|
2015
Q2 | $12.7M | Buy |
31,362
+10,944
| +54% | +$4.39M | 0.43% | 61 |
|
|
2015
Q1 | $8.62M | Buy |
20,418
+18,672
| +1,069% | +$7.36M | 0.29% | 78 |
|
|
2014
Q4 | $593K | Sell |
1,746
-3
| -0.2% | -$971 | 0.02% | 284 |
|
|
2014
Q3 | $578K | Sell |
1,749
-352
| -17% | -$116K | 0.02% | 291 |
|
|
2014
Q2 | $662K | Buy |
2,101
+55
| +3% | +$16.6K | 0.02% | 239 |
|
|
2014
Q1 | $625K | Sell |
2,046
-71
| -3% | -$22.5K | 0.02% | 239 |
|
|
2013
Q4 | $591K | Sell |
2,117
-15
| -0.7% | -$3.88K | 0.02% | 250 |
|
|
2013
Q3 | $513K | Sell |
2,132
-140
| -6% | -$31.3K | 0.02% | 253 |
|
|
2013
Q2 | $488K | Buy |
+2,272
| New | +$485K | 0.02% | 253 |
|
Other funds holding BIIB
Johnson Investment Counsel's BIIB Position: Q2 2026 in Review
Johnson Investment Counsel reduced its Biogen (BIIB) stake by 2.4% in Q2 2026, selling an estimated $5.74K and leaving 1,216 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #765.
Johnson Investment Counsel first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.7M in Q2 2015. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Johnson Investment Counsel held 1,216 shares of Biogen worth $263K as of Q2 2026.
- Johnson Investment Counsel sold 30 Biogen shares in Q2 2026, an estimated $5.74K.
- Biogen made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #765 holding.
- Johnson Investment Counsel first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Johnson Investment Counsel's Biogen position peaked at $12.7M in Q2 2015.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.